Editorial Conflict of Interest Disclosure

(as of May 2025)

As part of good publication practices, all editors of the JAFES (Editor-in-Chief, Vice Editor-in-Chief, Associate Editors, Editorial Board and Advisers) are required to disclose on an annual basis, any potential conflict of interest, including current or recent financial relationships with any commercial entity whose products or services may be contained in the journal content. Disclosure represents a commitment to transparency and does not necessarily indicate a bias.  This policy follows the recommendations of the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).

The following were disclosed:

ELIZABETH PAZ-PACHECO | Editor-in-Chief | Prof. Pacheco receives grants for Metabolomics of DM Nephropathy from the Philippine Council for Health Research Development. She is a Past President of the Philippine College of Endocrinology, Diabetes and Metabolism (PCEDM).

CECILIA A. JIMENO | Vice Editor-in-Chief | Prof. Jimeno receives honoraria for lectures on lipid lowering drugs (Atorvastatin, Rosuvastatin, Ezetimibe, Insulin Glargine) from Organon, AstraZeneca, Merck, Menarini, Sanofi). She also receives support for attending meetings on various antidiabetic medications from GX Pharmaceuticals, LG Chem, Corbridge. She is the Treasurer/Member of the Board of Directors of the Philippine Lipid and Atherosclerosis Society (PLAS). She is a stockholder of the Metro Pasay Medical Center.

GABRIEL V. JASUL JR. | Associate Editor | Prof. Jasul received honoraria for lectures from Sanofi Aventis, Novo Nordisk, MSD, Boehringer Ingelheim, Abbott Nutrition, AstraZeneca, LRI- Therapharma, UMed and Woerwag.

MADE RATNA SARASWATI | Associate Editor | Prof. Saraswati receives honoraria for lectures from Merck, Zuellig Pharma Therapeutics,  Kalventis Sinergi Farma and Novo Nordisk.

NORLAILA MUSTAFA | Associate Editor | Prof. Mustafa Prof. Mustafa receives grants for lectures from Novo Nordisk, Astra Zeneca, Zuellig Pharma, Servier and Eli Lilly.

PROF. THAN THAN AYE | Associate Editor | Prof. Aye has nothing to disclose.

CHAICHARN DEEROCHANAWONG | Associate Editor | Prof. Deerochanawong has nothing to disclose.

NGUYEN THY KHUE |Associate Editor | Assoc. Prof. Khue receives consulting fees from Merck. She
receives honoraria for lectures from Servier, Boehringer Ingelheim and Novo Nordisk. She is an Advisory Board of Merck Serono.

MARY ANN R. ABACAN | Editorial Board Member |  Prof. Abacan receives grants as principal investigator of the Registry of Lysosomal Storage Disorders from Sanofi Genzyme (2014 to present) and as co-investigator of the SHP-ELA-401 - A Long-Term, Open-Label, Multicenter, Phase IV Study to Assess Longitudinal Changes on Height and Weight in Patients with MPS II who are receiving Elaprase and started Treatment with Elaprase at <6 Years of Age - Shire (2015-present). She is a Consultant Medical
Specialist at the Institute of Human Genetics at the University of the Philippines-National Institutes of Health. She received honoraria as a lecturer of the Acute and Chronic Management of Organic and Amino Acidurias Training by Nutricia and Workshop for Dietitians (April 26, 2025). She is a co-chair of the National Transplant Ethics Committee of the Department of Health and of the Metabolic Experts Panel at the Newborn Screening Reference Center of the National Institutes of Health.

LORNA R. ABAD | Editorial Board Member | Prof. Abad has nothing to disclose.

MARISSA M. ALEJANDRIA | Editorial Board Member |Prof. Alejandria received research grants from the
Department of Science and Technology – Philippine Council for Health Research and Development and from CRDF Global.

PIA D. BAGAMASBAD | Editorial Board Member | Prof. Bagamasbad received grant funding from the Department of Science and Technology-Philippine Council for Health Research Development (DOST-PCHRD) to conduct research on prostate cancer and SARS-CoV-2 and the DOST-National Academy of Science and Technology (NAST) to conduct research on prostate cancer. She received honoraria as a plenary speaker of the Philippine College of Endocrinology, Diabetes and Metabolism (PCEDM) and the Philippine Society of Medical Oncology (PSMO). She is a member of the Endocrine (ENDO) Society (no financial involvement).

SARAT SUNTHORNYOTHIN | Editorial Board Member | Prof. Sarat has nothing to disclose.

NATTAPOL SATHAVARODOM | Editorial Board Member | Prof. Nattapol has nothing to disclose.

CHIAW LING CHNG | Editorial Board Member | Dr. Chng has nothing to disclose.

TINT SWE LATT | Editorial Board Member | Prof. Latt has nothing to disclose.

KHOO CHIN MENG | Editorial Board Member | Dr. Meng has nothing to disclose.

NURAIN MOHD NOOR | Editorial Board Member | Dr. Noor is the current President of the Malaysian Endocrine and Metabolic Society (MEMS).

NATHANIEL S. ORILLAZA JR. | Editorial Board Member | Dr. Orillaza receives research grants from the Department of Science and Technology to establish the Discovery and Innovation Hub. He also receives innovation grant research from the Philippine General Hospital. He receives honoraria as Advisory Board and member of the Speakers Bureau of Viatris. He is also a member of the Speakers Bureau of Menarini and Taisho. He receives support from Viatris and AO Foundation to attend lecture meetings. He has a
pending patent for medical devices. He is a Research Officer of AO Foundation.

PAUL MATTHEW D. PASCO| Editorial Board Member | Dr. Pasco has nothing to disclose.

CATHERINE LYNN T. SILAO| Editorial Board Member | Dr. Silao receives research grants from the Newborn Screening Reference Center, National Institutes of Health, Department of Science and Technology-Philippine Council for Health Research Development (DOST-PCHRD). She receives honoraria for lectures and manuscript writing from Nestle Nutrition Institute. She receives support for attending meetings at the Asia Pacific Society of Human Genetics, Medical Genetics and Genomics Association in
Thailand and Universitas Yarsi in Indonesia. She is part of the research group for the Methods and Means for Prognosticating the Occurrence of Pulmonary Complications in Leptospirosis and Early Diagnosis and Prognosis of Complicated Leptospirosis using Molecular Markers. She is the Secretary/Board of Director of the Asia Pacific Society of Human Genetics (no financial involvement) and member of the Human Genome Education Committee (no financial involvement). She is a stockholder of the Clinical Genetics
and Genomic Counseling Care Services (CGGCCS) Inc.

ROGELIO V. TANGCO | Editorial Board Member | Dr. Tangco has nothing to disclose.

NGUYEN VAN TUAN | Editorial Board Member | Prof. Van Tuan received financial support from the Australian National Health and Medical Research Council for his research. He also received a grant from Amgen to conduct research in osteoporosis. He is a member of Healthy Bone Australia (no financial involvement). 

MYO WIN | Editorial Board Member | Prof. Win has nothing to disclose.

MARITA V.T. REYES | Ethics Adviser | Dr. Reyes received a research grant to the Women's Health
Care Foundation from the Philippine Council for Health Research and Development. She receives honoraria as Department of Science and Technology-Philippine Council (DOST-PCHRD) Philippine Health Research Ethics Board. She is the President and Chair of the Board of Trustees of the Women's Health Care Foundation (WHCF), Inc. She is a stockholder of Makati Medical Center, Manila Doctors Hospital, The Medical City.

AMADO O. TANDOC III | Editorial Coordinator | Dr. Tandoc receives fees as a Consultant Editor of the Scientific Proceedings of the Lung Center of the Philippines, Philippine Journal of Orthopaedics and the Philippine Journal of Allergy, Asthma and Immunology. He is also the Editor-in-Chief of the Philippine Journal of Pathology. He is a speaker and Treasurer of the Philippine Association of Medical Journal Editors (PAMJE).